4886
Asuka Pharmaceutical Holdings Co., Ltd.
2026/03/23
Asuka Pharmaceutical Holdings has formulated the long-term vision "ASKA VISION 2035" looking ahead to 2035 and the "Medium-Term Management Plan 2028" for the three years starting fiscal 2026, targeting net sales of 85 billion yen and an operating income margin of 10%.
